Concepts (260)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Chagas Disease | 28 | 2026 | 319 | 7.380 |
Why?
|
| Trypanosoma cruzi | 28 | 2026 | 255 | 6.800 |
Why?
|
| Chagas Cardiomyopathy | 6 | 2021 | 46 | 2.270 |
Why?
|
| Nitroimidazoles | 6 | 2026 | 49 | 2.100 |
Why?
|
| Trypanocidal Agents | 5 | 2026 | 33 | 1.930 |
Why?
|
| Vaccines | 6 | 2023 | 386 | 1.910 |
Why?
|
| Protozoan Vaccines | 12 | 2026 | 101 | 1.870 |
Why?
|
| Facial Nerve Injuries | 5 | 2022 | 7 | 1.760 |
Why?
|
| Antibodies, Protozoan | 7 | 2026 | 102 | 1.730 |
Why?
|
| Motor Neurons | 6 | 2022 | 133 | 1.540 |
Why?
|
| Facial Nucleus | 2 | 2022 | 2 | 1.180 |
Why?
|
| Helminth Proteins | 2 | 2026 | 104 | 1.040 |
Why?
|
| Antigens, Protozoan | 6 | 2026 | 77 | 1.000 |
Why?
|
| Antibody Formation | 3 | 2025 | 226 | 0.920 |
Why?
|
| Mice, Inbred BALB C | 15 | 2026 | 979 | 0.890 |
Why?
|
| Amyotrophic Lateral Sclerosis | 3 | 2018 | 158 | 0.890 |
Why?
|
| Parasites | 2 | 2023 | 33 | 0.830 |
Why?
|
| Protozoan Proteins | 5 | 2026 | 128 | 0.830 |
Why?
|
| Superoxide Dismutase | 2 | 2015 | 173 | 0.810 |
Why?
|
| Animals | 45 | 2026 | 33660 | 0.800 |
Why?
|
| Mice | 28 | 2026 | 18160 | 0.780 |
Why?
|
| Ascaris suum | 3 | 2020 | 32 | 0.740 |
Why?
|
| Oxidative Stress | 1 | 2026 | 790 | 0.670 |
Why?
|
| Facial Nerve | 2 | 2018 | 25 | 0.650 |
Why?
|
| Monkey Diseases | 1 | 2020 | 17 | 0.630 |
Why?
|
| Connective Tissue Growth Factor | 1 | 2019 | 21 | 0.620 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 2019 | 40 | 0.610 |
Why?
|
| Lymphokines | 1 | 2019 | 62 | 0.610 |
Why?
|
| STAT3 Transcription Factor | 1 | 2021 | 226 | 0.600 |
Why?
|
| Microbiota | 2 | 2023 | 435 | 0.580 |
Why?
|
| Immunoglobulin G | 4 | 2026 | 781 | 0.570 |
Why?
|
| Protective Agents | 1 | 2018 | 34 | 0.560 |
Why?
|
| HLA-A Antigens | 1 | 2018 | 33 | 0.540 |
Why?
|
| Immunity, Cellular | 2 | 2022 | 198 | 0.540 |
Why?
|
| HLA-B Antigens | 1 | 2018 | 30 | 0.540 |
Why?
|
| Cytokines | 6 | 2026 | 1332 | 0.540 |
Why?
|
| Myocardium | 2 | 2019 | 859 | 0.530 |
Why?
|
| Recombinant Proteins | 6 | 2026 | 1319 | 0.510 |
Why?
|
| Central Nervous System Diseases | 1 | 2018 | 98 | 0.510 |
Why?
|
| Transforming Growth Factor beta | 1 | 2019 | 449 | 0.500 |
Why?
|
| Pregnancy Outcome | 1 | 2020 | 614 | 0.490 |
Why?
|
| Ascariasis | 4 | 2020 | 76 | 0.490 |
Why?
|
| Immunologic Memory | 1 | 2018 | 194 | 0.480 |
Why?
|
| Disease Models, Animal | 9 | 2026 | 4639 | 0.480 |
Why?
|
| Mice, Inbred C57BL | 8 | 2025 | 4691 | 0.460 |
Why?
|
| Vaccination | 8 | 2022 | 1052 | 0.440 |
Why?
|
| Axotomy | 3 | 2022 | 12 | 0.430 |
Why?
|
| Leishmania | 2 | 2023 | 34 | 0.380 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 2014 | 501 | 0.380 |
Why?
|
| Leishmaniasis | 2 | 2023 | 41 | 0.380 |
Why?
|
| Nerve Regeneration | 2 | 2019 | 69 | 0.370 |
Why?
|
| Interleukin-10 | 3 | 2022 | 187 | 0.360 |
Why?
|
| Flow Cytometry | 3 | 2026 | 765 | 0.350 |
Why?
|
| Female | 25 | 2026 | 70246 | 0.350 |
Why?
|
| Heart | 5 | 2023 | 659 | 0.350 |
Why?
|
| Antigens, Helminth | 5 | 2020 | 187 | 0.330 |
Why?
|
| Trichuriasis | 3 | 2022 | 31 | 0.320 |
Why?
|
| Immunization | 5 | 2022 | 269 | 0.310 |
Why?
|
| Antibodies, Helminth | 3 | 2020 | 131 | 0.300 |
Why?
|
| CD8-Positive T-Lymphocytes | 4 | 2022 | 460 | 0.290 |
Why?
|
| Adjuvants, Immunologic | 6 | 2026 | 391 | 0.290 |
Why?
|
| B-Lymphocytes | 4 | 2025 | 508 | 0.270 |
Why?
|
| Fibrosis | 2 | 2019 | 420 | 0.260 |
Why?
|
| Immunotherapy | 2 | 2026 | 758 | 0.250 |
Why?
|
| Superantigens | 2 | 2017 | 20 | 0.250 |
Why?
|
| Wallerian Degeneration | 1 | 2006 | 10 | 0.240 |
Why?
|
| RNA, Messenger | 3 | 2024 | 2548 | 0.230 |
Why?
|
| Superoxide Dismutase-1 | 2 | 2016 | 24 | 0.220 |
Why?
|
| Hepatomegaly | 1 | 2023 | 22 | 0.200 |
Why?
|
| Disease Progression | 3 | 2023 | 2191 | 0.200 |
Why?
|
| PPAR alpha | 1 | 2023 | 54 | 0.200 |
Why?
|
| Leishmania mexicana | 1 | 2023 | 6 | 0.200 |
Why?
|
| Interferon-gamma | 4 | 2019 | 542 | 0.190 |
Why?
|
| Mutation | 2 | 2017 | 6067 | 0.180 |
Why?
|
| Immunoglobulin M | 3 | 2018 | 207 | 0.180 |
Why?
|
| Th2 Cells | 2 | 2017 | 188 | 0.180 |
Why?
|
| Neuroprotection | 1 | 2022 | 32 | 0.180 |
Why?
|
| Th1 Cells | 2 | 2022 | 158 | 0.180 |
Why?
|
| RNA, Protozoan | 1 | 2021 | 10 | 0.180 |
Why?
|
| Metabolome | 2 | 2021 | 325 | 0.170 |
Why?
|
| Mice, Transgenic | 3 | 2016 | 2330 | 0.170 |
Why?
|
| Parasite Load | 2 | 2018 | 31 | 0.170 |
Why?
|
| Larva | 2 | 2018 | 240 | 0.170 |
Why?
|
| Tropism | 1 | 2020 | 7 | 0.170 |
Why?
|
| Antigenic Variation | 1 | 2021 | 37 | 0.170 |
Why?
|
| Humans | 22 | 2024 | 130085 | 0.160 |
Why?
|
| Mexico | 2 | 2018 | 190 | 0.160 |
Why?
|
| Interleukin-17 | 1 | 2021 | 125 | 0.160 |
Why?
|
| Phospholipids | 1 | 2020 | 100 | 0.150 |
Why?
|
| Endothelin-1 | 1 | 2019 | 40 | 0.150 |
Why?
|
| Seroepidemiologic Studies | 1 | 2020 | 158 | 0.150 |
Why?
|
| Cysteine | 2 | 2017 | 137 | 0.150 |
Why?
|
| Parasitemia | 1 | 2019 | 25 | 0.150 |
Why?
|
| Male Urogenital Diseases | 1 | 2019 | 15 | 0.150 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2020 | 141 | 0.150 |
Why?
|
| Leukocytes, Mononuclear | 2 | 2018 | 352 | 0.150 |
Why?
|
| Peripheral Nerve Injuries | 1 | 2019 | 37 | 0.150 |
Why?
|
| Mice, Inbred ICR | 1 | 2019 | 137 | 0.150 |
Why?
|
| Antibodies, Catalytic | 1 | 2018 | 7 | 0.140 |
Why?
|
| Swine Diseases | 1 | 2018 | 42 | 0.140 |
Why?
|
| Macaca mulatta | 1 | 2020 | 492 | 0.140 |
Why?
|
| Magnetic Resonance Imaging, Cine | 1 | 2019 | 172 | 0.140 |
Why?
|
| Liver | 1 | 2026 | 1783 | 0.140 |
Why?
|
| Electric Stimulation Therapy | 1 | 2019 | 90 | 0.140 |
Why?
|
| Spatio-Temporal Analysis | 1 | 2018 | 16 | 0.140 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2020 | 784 | 0.140 |
Why?
|
| Immunity | 1 | 2018 | 178 | 0.130 |
Why?
|
| Epitopes, T-Lymphocyte | 1 | 2018 | 126 | 0.130 |
Why?
|
| Polymerase Chain Reaction | 2 | 2018 | 1453 | 0.130 |
Why?
|
| Cell Death | 1 | 2018 | 226 | 0.130 |
Why?
|
| Immunophenotyping | 1 | 2018 | 332 | 0.130 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2021 | 951 | 0.130 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2018 | 194 | 0.130 |
Why?
|
| Spinal Cord | 1 | 2018 | 256 | 0.130 |
Why?
|
| Host-Parasite Interactions | 1 | 2016 | 71 | 0.120 |
Why?
|
| Recovery of Function | 1 | 2018 | 446 | 0.120 |
Why?
|
| Vaccines, Synthetic | 4 | 2022 | 324 | 0.120 |
Why?
|
| Gene Frequency | 1 | 2018 | 729 | 0.120 |
Why?
|
| Cell- and Tissue-Based Therapy | 1 | 2017 | 150 | 0.120 |
Why?
|
| Trichuris | 3 | 2022 | 26 | 0.120 |
Why?
|
| Insect Vectors | 1 | 2016 | 113 | 0.120 |
Why?
|
| Mice, Knockout | 2 | 2022 | 3810 | 0.120 |
Why?
|
| Immunohistochemistry | 2 | 2018 | 1592 | 0.120 |
Why?
|
| Laser Capture Microdissection | 1 | 2015 | 9 | 0.110 |
Why?
|
| Motor Disorders | 1 | 2015 | 7 | 0.110 |
Why?
|
| Motor Activity | 1 | 2018 | 488 | 0.110 |
Why?
|
| Cell Survival | 1 | 2018 | 828 | 0.110 |
Why?
|
| Fibroblasts | 1 | 2019 | 850 | 0.110 |
Why?
|
| Sensation Disorders | 1 | 2015 | 25 | 0.110 |
Why?
|
| Th17 Cells | 1 | 2016 | 97 | 0.110 |
Why?
|
| Spinal Cord Injuries | 1 | 2018 | 271 | 0.110 |
Why?
|
| Swine | 1 | 2018 | 1184 | 0.110 |
Why?
|
| Muscle Strength | 1 | 2015 | 77 | 0.110 |
Why?
|
| Acute Disease | 1 | 2018 | 1153 | 0.110 |
Why?
|
| Myocytes, Cardiac | 1 | 2019 | 670 | 0.100 |
Why?
|
| Echocardiography | 1 | 2019 | 1131 | 0.100 |
Why?
|
| Recombinant Fusion Proteins | 3 | 2023 | 688 | 0.100 |
Why?
|
| Transfection | 1 | 2015 | 961 | 0.100 |
Why?
|
| Vaccines, Combined | 2 | 2023 | 40 | 0.100 |
Why?
|
| Adoptive Transfer | 1 | 2014 | 235 | 0.100 |
Why?
|
| Histamine Release | 1 | 2012 | 10 | 0.090 |
Why?
|
| Basophils | 1 | 2012 | 11 | 0.090 |
Why?
|
| Hookworm Infections | 1 | 2014 | 127 | 0.090 |
Why?
|
| Immunoglobulin Fc Fragments | 1 | 2012 | 28 | 0.090 |
Why?
|
| Sequence Analysis, DNA | 1 | 2018 | 1690 | 0.090 |
Why?
|
| Necator americanus | 1 | 2012 | 93 | 0.090 |
Why?
|
| Genotype | 1 | 2018 | 2588 | 0.090 |
Why?
|
| Global Health | 1 | 2016 | 622 | 0.090 |
Why?
|
| HIV Infections | 1 | 2024 | 2043 | 0.090 |
Why?
|
| Immunoglobulin E | 1 | 2012 | 215 | 0.090 |
Why?
|
| Genetic Variation | 1 | 2018 | 1544 | 0.080 |
Why?
|
| Male | 5 | 2020 | 64386 | 0.080 |
Why?
|
| Lung | 1 | 2018 | 1531 | 0.080 |
Why?
|
| Cell Proliferation | 1 | 2018 | 2462 | 0.080 |
Why?
|
| Biomarkers | 1 | 2019 | 3358 | 0.080 |
Why?
|
| Interleukin-4 | 2 | 2022 | 144 | 0.080 |
Why?
|
| Feeding Behavior | 1 | 2015 | 710 | 0.080 |
Why?
|
| Age Factors | 1 | 2015 | 2822 | 0.070 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2019 | 3741 | 0.070 |
Why?
|
| Leishmania major | 1 | 2007 | 27 | 0.070 |
Why?
|
| Pregnancy | 1 | 2020 | 7390 | 0.060 |
Why?
|
| Leishmaniasis, Cutaneous | 1 | 2007 | 50 | 0.060 |
Why?
|
| Soil | 2 | 2020 | 76 | 0.060 |
Why?
|
| DNA-Binding Proteins | 1 | 2014 | 1931 | 0.060 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2006 | 60 | 0.060 |
Why?
|
| Receptors, Cell Surface | 1 | 2007 | 419 | 0.060 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2007 | 239 | 0.060 |
Why?
|
| Forkhead Transcription Factors | 1 | 2007 | 373 | 0.050 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2024 | 107 | 0.050 |
Why?
|
| Lymphocyte Activation | 1 | 2006 | 630 | 0.050 |
Why?
|
| Technology | 1 | 2024 | 68 | 0.050 |
Why?
|
| Dogs | 2 | 2016 | 615 | 0.050 |
Why?
|
| Survival Analysis | 2 | 2017 | 1481 | 0.050 |
Why?
|
| Tissue Distribution | 1 | 2024 | 362 | 0.050 |
Why?
|
| Campylobacter jejuni | 1 | 2003 | 6 | 0.050 |
Why?
|
| Campylobacter Infections | 1 | 2003 | 33 | 0.050 |
Why?
|
| HIV | 1 | 2024 | 173 | 0.050 |
Why?
|
| Sus scrofa | 1 | 2003 | 112 | 0.050 |
Why?
|
| Antiparasitic Agents | 1 | 2022 | 28 | 0.050 |
Why?
|
| Mice, Inbred AKR | 1 | 2022 | 15 | 0.050 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2024 | 510 | 0.040 |
Why?
|
| Administration, Intranasal | 1 | 2022 | 130 | 0.040 |
Why?
|
| Mucous Membrane | 1 | 2022 | 92 | 0.040 |
Why?
|
| Hybridomas | 1 | 2021 | 30 | 0.040 |
Why?
|
| Retrospective Studies | 1 | 2020 | 17541 | 0.040 |
Why?
|
| Immunity, Mucosal | 1 | 2022 | 95 | 0.040 |
Why?
|
| Synteny | 1 | 2021 | 66 | 0.040 |
Why?
|
| Immunoglobulin A | 1 | 2022 | 200 | 0.040 |
Why?
|
| Epitopes | 1 | 2022 | 323 | 0.040 |
Why?
|
| RNA | 1 | 2024 | 509 | 0.040 |
Why?
|
| Antibodies, Monoclonal | 2 | 2021 | 977 | 0.040 |
Why?
|
| Colon | 1 | 2003 | 363 | 0.040 |
Why?
|
| Multigene Family | 1 | 2021 | 289 | 0.040 |
Why?
|
| Aged | 1 | 2018 | 20821 | 0.040 |
Why?
|
| Neurotrophin 3 | 1 | 2018 | 13 | 0.040 |
Why?
|
| Thoracic Vertebrae | 1 | 2018 | 74 | 0.030 |
Why?
|
| Schwann Cells | 1 | 2018 | 61 | 0.030 |
Why?
|
| Phylogeny | 1 | 2020 | 684 | 0.030 |
Why?
|
| Middle Aged | 1 | 2018 | 28314 | 0.030 |
Why?
|
| Sequence Analysis | 1 | 2017 | 50 | 0.030 |
Why?
|
| Cholera Toxin | 1 | 2017 | 40 | 0.030 |
Why?
|
| Neuromuscular Junction | 1 | 2018 | 87 | 0.030 |
Why?
|
| Models, Animal | 1 | 2019 | 449 | 0.030 |
Why?
|
| Interleukin-5 | 1 | 2017 | 49 | 0.030 |
Why?
|
| Hydrolysis | 1 | 2017 | 140 | 0.030 |
Why?
|
| Dendrites | 1 | 2018 | 180 | 0.030 |
Why?
|
| Dependovirus | 1 | 2018 | 159 | 0.030 |
Why?
|
| Coyotes | 1 | 2016 | 4 | 0.030 |
Why?
|
| Adult | 1 | 2018 | 31011 | 0.030 |
Why?
|
| Animals, Domestic | 1 | 2016 | 40 | 0.030 |
Why?
|
| Drug Carriers | 1 | 2017 | 118 | 0.030 |
Why?
|
| Transduction, Genetic | 1 | 2017 | 276 | 0.030 |
Why?
|
| Synaptic Transmission | 1 | 2018 | 300 | 0.030 |
Why?
|
| Serine | 1 | 2017 | 161 | 0.030 |
Why?
|
| T-Lymphocytopenia, Idiopathic CD4-Positive | 1 | 2016 | 2 | 0.030 |
Why?
|
| Housing | 1 | 2016 | 74 | 0.030 |
Why?
|
| Triatoma | 1 | 2016 | 35 | 0.030 |
Why?
|
| Protein Isoforms | 1 | 2017 | 422 | 0.030 |
Why?
|
| Amino Acid Sequence | 1 | 2020 | 2392 | 0.030 |
Why?
|
| Sequence Alignment | 1 | 2017 | 583 | 0.030 |
Why?
|
| Calcium-Binding Proteins | 1 | 2017 | 322 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2018 | 1109 | 0.030 |
Why?
|
| Mutagenesis | 1 | 2016 | 324 | 0.030 |
Why?
|
| Antibody Specificity | 1 | 2015 | 164 | 0.030 |
Why?
|
| Cell Differentiation | 1 | 2023 | 1906 | 0.030 |
Why?
|
| Adenoviridae | 1 | 2017 | 581 | 0.030 |
Why?
|
| Dendritic Cells | 1 | 2017 | 435 | 0.030 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2017 | 399 | 0.030 |
Why?
|
| Immunity, Innate | 1 | 2017 | 405 | 0.030 |
Why?
|
| Cost of Illness | 1 | 2016 | 293 | 0.030 |
Why?
|
| Ascaris lumbricoides | 1 | 2014 | 19 | 0.030 |
Why?
|
| Genetic Vectors | 1 | 2017 | 892 | 0.030 |
Why?
|
| Anthelmintics | 1 | 2014 | 55 | 0.020 |
Why?
|
| Ancylostomatoidea | 1 | 2014 | 60 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2018 | 2885 | 0.020 |
Why?
|
| Alum Compounds | 1 | 2012 | 41 | 0.020 |
Why?
|
| Pichia | 1 | 2012 | 56 | 0.020 |
Why?
|
| Vaccines, Subunit | 1 | 2012 | 74 | 0.020 |
Why?
|
| Cricetinae | 1 | 2012 | 361 | 0.020 |
Why?
|
| Immunoglobulins | 1 | 2012 | 153 | 0.020 |
Why?
|
| Muscle, Skeletal | 1 | 2018 | 980 | 0.020 |
Why?
|
| Hypersensitivity | 1 | 2012 | 226 | 0.020 |
Why?
|
| Prevalence | 1 | 2016 | 2687 | 0.020 |
Why?
|
| Skin | 1 | 2012 | 538 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2015 | 3349 | 0.020 |
Why?
|
| United States | 1 | 2024 | 11896 | 0.020 |
Why?
|
| Gene Expression | 1 | 2012 | 1482 | 0.020 |
Why?
|
| Texas | 1 | 2016 | 3655 | 0.020 |
Why?
|
| Interleukin-4 Receptor alpha Subunit | 1 | 2007 | 13 | 0.020 |
Why?
|
| Ear | 1 | 2007 | 26 | 0.020 |
Why?
|
| Dermis | 1 | 2007 | 26 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2015 | 2322 | 0.020 |
Why?
|
| Lymphocyte Depletion | 1 | 2007 | 124 | 0.020 |
Why?
|
| Interleukin-13 | 1 | 2007 | 97 | 0.020 |
Why?
|
| Lymph Nodes | 1 | 2007 | 356 | 0.010 |
Why?
|
| Microscopy, Electron | 1 | 2003 | 305 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2017 | 12821 | 0.010 |
Why?
|
| Inflammation | 1 | 2007 | 1478 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2007 | 3404 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2007 | 4645 | 0.010 |
Why?
|